Coalition reaffirms bipartisan support for PBS as Trump’s 200 per cent pharma tariff threat targets Australia

The Coalition asserts bipartisan support for Australia’s Pharmaceutical Benefits Scheme (PBS) amid Donald Trump’s proposed 200% tariff on pharmaceutical imports, which threatens the scheme’s price negotiation requirement. Senior senator Bridget McKenzie emphasized the PBS’s role in universal healthcare while criticizing the Albanese government’s handling of U.S. relations, highlighting the lack of communication on various economic issues.

Explain It To Me Like I’m 5: The Coalition supports the Pharmaceutical Benefits Scheme (PBS), which helps Australians access affordable medicines, as they face pressure from the U.S. to change it due to potential tariffs.

Want More Context? 🔎